全球智库信息集成服务系统

Our survey and interview findings show that the SBRI Healthcare programme is providing effective support for small companies to develop innovations that address NHS needs.

The programme has a number of strengths, including low administrative burdens for applicants and awardees, effective processes for identifying and articulating needs, and a beneficial provision of health economics support in Phase 1.

However, addressing NHS needs entails going beyond innovation development to include uptake and use of the innovations. This step constitutes a fundamental challenge and will require collaboration with other innovation programmes.

Part of this could include:

• Ensuring that the AHSNs are well informed about who the SBRI Healthcare-supported companies are in their region and their stage of development.
• Ensuring there is clear guidance for the AHSNs about how they could support SBRI-supported companies.
• Providing networking opportunities for companies to learn from one another.
• Explore opportunities to engage with other national and regional funding programmes.

The SBRI Healthcare programme performs a valuable role for the NHS in the early-stage innovation funding landscape. Going forward it will be important to consider how best to coordinate the SBRI Healthcare programme with wider policy developments (including the Accelerated Access Review) and initiatives to progress the adoption, diffusion and scale-up in the NHS of the innovations it supports.

This study explores the contribution of the Small Business Research Initiative (SBRI) Healthcare programme to innovation in the NHS (National Health Service). It was commissioned by the UK Department of Health Policy Research Programme. It is related to a wider, two-year study of innovation in the NHS being conducted by RAND Europe and the University of Manchester, but represents a discrete stream of work.

In this report, we introduce the background and context for the SBRI Healthcare study, describe the interview and survey methods used. and discuss the main results and conclusions.

Our survey and interview findings show that the SBRI Healthcare programme is providing effective support for small companies to develop innovations that address NHS needs. The programme has a number of strengths, including low administrative burdens for applicants and awardees, effective processes for identifying and articulating needs, and a beneficial provision of health economics support in Phase 1. Addressing NHS needs, however, entails going beyond innovation development to include uptake and use of the innovations. This step constitutes a fundamental challenge and will require collaboration with other innovation programmes.

• Chapter One

  Introduction

• Chapter Two

  Methods

• Chapter Three

  Results

• Chapter Four

  Conclusions

• Appendix A

  Report on survey of companies that applied unsuccessfully for SBRI Healthcare support

• Appendix B

  Report on SBRI Healthcare programme stakeholder interviews

• Appendix C

  Report on survey of companies that received SBRI Healthcare support

• Appendix D

  Detailed methods for interviews with SBRI Healthcare award recipients